Cardiac microphysiological devices with flexible thin-film sensors for higher-throughput drug screening.

Microphysiological systems and organs-on-chips promise to accelerate biomedical and pharmaceutical research by providing accurate in vitro replicas of human tissue. Aside from addressing the physiological accuracy of the model tissues, there is a pressing need for improving the throughput of these platforms. To do so, scalable data acquisition strategies must be introduced. To this end, we here present an instrumented 24-well plate platform for higher-throughput studies of engineered human stem cell-derived cardiac muscle tissues that recapitulate the laminar structure of the native ventricle. In each well of the platform, an embedded flexible strain gauge provides continuous and non-invasive readout of the contractile stress and beat rate of an engineered cardiac tissue. The sensors are based on micro-cracked titanium-gold thin films, which ensure that the sensors are highly compliant and robust. We demonstrate the value of the platform for toxicology and drug-testing purposes by performing 12 complete dose-response studies of cardiac and cardiotoxic drugs. Additionally, we showcase the ability to couple the cardiac tissues with endothelial barriers. In these studies, which mimic the passage of drugs through the blood vessels to the musculature of the heart, we regulate the temporal onset of cardiac drug responses by modulating endothelial barrier permeability in vitro.

[1]  R. W. Hansen,et al.  Journal of Health Economics , 2016 .

[2]  B. Duling,et al.  TNF-α increases entry of macromolecules into luminal endothelial cell glycocalyx , 2000 .

[3]  Kumaraswamy Nanthakumar,et al.  Design and formulation of functional pluripotent stem cell-derived cardiac microtissues , 2013, Proceedings of the National Academy of Sciences.

[4]  Megan L. McCain,et al.  Coupling primary and stem cell – derived cardiomyocytes in an in vitro model of cardiac cell therapy , 2022 .

[5]  Kevin Kit Parker,et al.  Structural Phenotyping of Stem Cell-Derived Cardiomyocytes , 2015, Stem cell reports.

[6]  G. Breithardt,et al.  Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycin. , 1998, Journal of cardiovascular pharmacology.

[7]  Josue A. Goss,et al.  Microfluidic heart on a chip for higher throughput pharmacological studies. , 2013, Lab on a chip.

[8]  Ivan Rusyn,et al.  Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity. , 2013, Toxicology and applied pharmacology.

[9]  M. Diaz,et al.  Effects of mefloquine on cardiac contractility and electrical activity in vivo, in isolated cardiac preparations, and in single ventricular myocytes , 2000, British journal of pharmacology.

[10]  S. Wagner,et al.  Controlling the morphology of gold films on poly(dimethylsiloxane). , 2010, ACS applied materials & interfaces.

[11]  D. Brutsaert,et al.  Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. , 2003, Physiological reviews.

[12]  Eva Wagner,et al.  Physiologic force-frequency response in engineered heart muscle by electromechanical stimulation. , 2015, Biomaterials.

[13]  M. Simons,et al.  Cell Communications in the Heart , 2010, Circulation.

[14]  Kevin Kit Parker,et al.  Micromolded gelatin hydrogels for extended culture of engineered cardiac tissues. , 2014, Biomaterials.

[15]  G. Buckberg,et al.  Ventricular structure-function relations in health and disease: Part I. The normal heart. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[16]  S. Matalon,et al.  Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability. , 1989, The American journal of physiology.

[17]  Stéphanie P. Lacour,et al.  Extended cyclic uniaxial loading of stretchable gold thin-films on elastomeric substrates , 2009 .

[18]  D. Beebe,et al.  PDMS absorption of small molecules and consequences in microfluidic applications. , 2006, Lab on a chip.

[19]  Sung-Jin Park,et al.  Instrumented cardiac microphysiological devices via multi-material 3D printing , 2016, Nature materials.

[20]  M. Radisic,et al.  Biodegradable scaffold with built-in vasculature for organ-on-a-chip engineering and direct surgical anastomosis , 2016, Nature materials.

[21]  Kevin E. Healy,et al.  Miniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses , 2016, Scientific Reports.

[22]  Nenad Bursac,et al.  Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. , 2013, Biomaterials.

[23]  Pal Pacher,et al.  Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? , 2004, Current pharmaceutical design.

[24]  Megan L. McCain,et al.  Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip. , 2011, Lab on a chip.

[25]  J. Coleman,et al.  Sensitive electromechanical sensors using viscoelastic graphene-polymer nanocomposites , 2016, Science.

[26]  Francisco Torrent-Guasp,et al.  The helical ventricular myocardial band: global, three-dimensional, functional architecture of the ventricular myocardium. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[27]  P. Nava,et al.  Critical Role of Tight Junctions in Drug Delivery across Epithelial and Endothelial Cell Layers , 2005, The Journal of Membrane Biology.

[28]  H L Greene,et al.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.

[29]  Divya Rajamohan,et al.  Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation , 2011, European heart journal.

[30]  M. Böhm,et al.  Negative Inotropic Properties of Isradipine, Nifedipine, Diltiazem, and Verapamil in Diseased Human Myocardial Tissue , 1990, Journal of cardiovascular pharmacology.

[31]  Thomas Boudou,et al.  A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. , 2012, Tissue engineering. Part A.

[32]  L. Miller Cardiovascular Toxicities of Immunosuppressive Agents , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[33]  Lisa J. McQuay,et al.  Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case‐control study , 2010, Pharmacoepidemiology and drug safety.

[34]  W. Zimmermann,et al.  Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. , 2000, Biotechnology and bioengineering.

[35]  U. Borchard,et al.  Effect of Flecainide on Action Potentials and Alternating Current‐Induced Arrhythmias in Mammalian Myocardium , 1982, Journal of cardiovascular pharmacology.

[36]  Gang Wang,et al.  Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014 .

[37]  Marco F. Ramoni,et al.  Clinical forecasting in drug development , 2007, Nature Reviews Drug Discovery.

[38]  Mark D. Huffman,et al.  Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[39]  Luke P. Lee,et al.  Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications , 2015, Scientific Reports.

[40]  P Smith,et al.  Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.

[41]  L. Jordaens,et al.  Atrial flutter with 1: 1 conduction after administration of the antimalarial drug mefloquine , 1996, Clinical cardiology.

[42]  Donald E Ingber,et al.  Measuring direct current trans-epithelial electrical resistance in organ-on-a-chip microsystems. , 2015, Lab on a chip.

[43]  Sigurd Wagner,et al.  Mechanisms of reversible stretchability of thin metal films on elastomeric substrates , 2006 .

[44]  P. Hunter,et al.  Laminar structure of the heart: ventricular myocyte arrangement and connective tissue architecture in the dog. , 1995, The American journal of physiology.

[45]  S. Hohnloser Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management. , 1997, The American journal of cardiology.

[46]  E. Seidman,et al.  Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients , 1995, The Lancet.

[47]  G. Whitesides,et al.  Muscular Thin Films for Building Actuators and Powering Devices , 2007, Science.

[48]  Jean-Pierre Valentin,et al.  Safety and secondary pharmacology: successes, threats, challenges and opportunities. , 2008, Journal of pharmacological and toxicological methods.

[49]  C. January,et al.  Block of HERG Potassium Channels by the Antihistamine Astemizole and its Metabolites Desmethylastemizole and Norastemizole , 1999, Journal of cardiovascular electrophysiology.

[50]  M. Endoh Force-frequency relationship in intact mammalian ventricular myocardium: physiological and pathophysiological relevance. , 2004, European journal of pharmacology.